New Risk • Aug 07
New minor risk - Financial position The company has a high level of debt. Net debt to equity ratio: 136% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (136% net debt to equity). Significant insider selling over the past 3 months (€4.2m sold). Reported Earnings • Aug 07
Second quarter 2026 earnings released: EPS: CA$0.32 (vs CA$0.38 in 2Q 2025) Second quarter 2026 results: EPS: CA$0.32 (down from CA$0.38 in 2Q 2025). Revenue: CA$611.0m (up 59% from 2Q 2025). Net income: CA$30.9m (down 3.4% from 2Q 2025). Profit margin: 5.0% (down from 8.3% in 2Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has increased by 61% per year, which means it is tracking significantly ahead of earnings growth. Declared Dividend • Jul 20
Dividend of CA$0.044 announced Shareholders will receive a dividend of CA$0.044. Ex-date: 31st July 2026 Payment date: 17th August 2026 Dividend yield will be 1.4%, which is lower than the industry average of 3.3%. Sustainability & Growth Dividend is covered by both earnings (36% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 19% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Aankondiging • Jul 16
Extendicare Announces July 2026 Dividend, Payable on August 17, 2026 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.0441 per common share of the Company for the month of July 2026, which is payable on August 17, 2026 to shareholders of record at the close of
business on July 31, 2026. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). Aankondiging • Jul 07
Extendicare Inc. to Report Q2, 2026 Results on Aug 06, 2026 Extendicare Inc. announced that they will report Q2, 2026 results After-Market on Aug 06, 2026 Declared Dividend • Jun 25
Dividend of CA$0.044 announced Shareholders will receive a dividend of CA$0.044. Ex-date: 30th June 2026 Payment date: 15th July 2026 Dividend yield will be 1.6%, which is lower than the industry average of 3.3%. Sustainability & Growth Dividend is covered by both earnings (36% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 19% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Aankondiging • Jun 15
Extendicare Inc. Declares Cash Dividend for the Month of June 2026, Payable on July 15, 2026 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.0441 per common share of the Company for the month of June 2026, which is payable on July 15, 2026 to shareholders of record at the close of business on June 30, 2026. Declared Dividend • May 20
Dividend of CA$0.044 announced Shareholders will receive a dividend of CA$0.044. Ex-date: 29th May 2026 Payment date: 15th June 2026 Dividend yield will be 1.6%, which is lower than the industry average of 3.3%. Sustainability & Growth Dividend is covered by both earnings (36% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 19% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Aankondiging • May 09
Extendicare Inc. Declares Cash Dividend for the Month of May 2026, Payable on June 15, 2026 The Board of Directors of Extendicare declared a cash dividend of CAD 0.0441 per share for the month of May 2026, which is payable on June 15, 2026, to shareholders of record at the close of business on May 29, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Aankondiging • Apr 06
Extendicare Inc. to Report Q1, 2026 Results on May 07, 2026 Extendicare Inc. announced that they will report Q1, 2026 results After-Market on May 07, 2026 Aankondiging • Mar 19
Extendicare Inc. Announces Alan Torrie, Chair of the Board, and Donna Kingelin, Board Member, Will Not Stand for Re-Election Extendicare Inc. announced that current Board members Alan Torrie, Chair of the Board, and Donna Kingelin will not stand for re-election at the Meeting following over 10 years of service. Alan’s leadership and vision during his nine years as Chair enabled the transition of Extendicare from its real estate focus to a new business model focused on health services. Donna chaired the HR Committee and subsequently the Quality and Risk Committee during her tenure, building pivotal capabilities that are core to the Company’s health services mandate. Aankondiging • Feb 27
Extendicare Inc. Increases Cash Dividend for the Month of March 2026 Extendicare Inc. is increasing its monthly dividend by 5% to 4.41 cents per share, effective with the dividend to be declared in March 2026. Building on the 5% increase last year, the increase reflects the sustained operating performance throughout 2025 and sound capital structure. Continued strong performance would give the Company the opportunity to consider further dividend increases. Aankondiging • Feb 17
Extendicare Inc. Declares Cash Dividend for the Month of February 2026, Payable on March 16, 2026 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of February 2026, which is payable on March 16, 2026 to shareholders of record at the close of business on February 27, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Aankondiging • Jan 27
Extendicare Inc., Annual General Meeting, Apr 16, 2026 Extendicare Inc., Annual General Meeting, Apr 16, 2026. Aankondiging • Jan 16
Extendicare Inc. to Report Q4, 2025 Results on Feb 26, 2026 Extendicare Inc. announced that they will report Q4, 2025 results at 4:00 PM, US Eastern Standard Time on Feb 26, 2026 Aankondiging • Jan 15
Extendicare Inc. Declares Cash Dividend for the Month of January 2026, Payable on February 16, 2026 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of January 2026, which is payable on February 16, 2026 to shareholders of record at the close of business on January 30, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Aankondiging • Dec 13
Extendicare Inc. Declares Cash Dividend on Common Share for the Month of December 2025, Payable on January 15, 2026 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of December 2025, which is payable on January 15, 2026 to shareholders of record at the close of business on December 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Aankondiging • Nov 20
Extendicare Inc. (TSX:EXE) entered into a definitive agreement to acquire CBI Home Health from CBI Health Group Inc. for $570 million. Extendicare Inc. (TSX:EXE) entered into a definitive agreement to acquire CBI Home Health from CBI Health Group Inc. for $570 million on November 19, 2025. The transaction will be financed through cash on hand, proceeds from the Offering of $192 million and senior debt of $264.5 million.
For the period ending July 31, 2025, CBI Home Health reported total revenue of $478 million and EBITDA of $62 million.
The transaction is subject to customary closing conditions, including receipt of consents from third parties, including Ontario Health atHome and Assisted Living Alberta, and regulatory approval pursuant to the Competition Act. The transaction is expected to close in the first quarter of 2026. The transaction will be immediately accretive to earnings per share.
CIBC Capital Markets, Research Division acted as financial advisor for Extendicare Inc. Torys LLP acted as legal advisor for Extendicare Inc. Houlihan Lokey, Inc. acted as financial advisor for CBI Home Health. TD Securities, Inc. acted as financial advisor for CBI Home Health. Stikeman Elliott LLP acted as legal advisor for CBI Home Health. Aankondiging • Nov 13
Extendicare Inc. announces Monthly dividend, payable on December 15, 2025 Extendicare Inc. announced Monthly dividend of CAD 0.0420 per share payable on December 15, 2025, ex-date on November 28, 2025 and record date on November 28, 2025. Aankondiging • Oct 15
Extendicare Inc. Declares Cash Dividend on Common Share for the Month of October 2025, Payable on November 17, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of October 2025, which is payable on November 17, 2025 to shareholders of record at the close of business on October 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Aankondiging • Oct 07
Extendicare Inc. to Report Q3, 2025 Results on Nov 11, 2025 Extendicare Inc. announced that they will report Q3, 2025 results After-Market on Nov 11, 2025 Aankondiging • Sep 15
Extendicare Inc. Announces September 2025 Dividend, Payable on October 15, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of September 2025, which is payable on October 15, 2025 to shareholders of record at the close of business on September 30, 2025. Aankondiging • Aug 07
Extendicare Inc. Declares Cash Dividend for the Month of August 2025, Payable on September 15, 2025 The Board of Directors of Extendicare declared a cash dividend of $0.042 per share for the month of August 2025, which is payable on September 15, 2025, to shareholders of record at the close of business on August 29, 2025. Aankondiging • Jul 15
Extendicare Inc. Declares Cash Dividend for the Month of July 2025, Payable on August 15, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of July 2025, which is payable on August 15, 2025 to shareholders of record at the close of business on July 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Aankondiging • Jul 07
Extendicare Inc. to Report Q2, 2025 Results on Aug 06, 2025 Extendicare Inc. announced that they will report Q2, 2025 results After-Market on Aug 06, 2025 Aankondiging • Jun 18
Extendicare Inc. Declares Cash Dividend for the Month of June 2025, Payable on July 15, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of June 2025, which is payable on July 15, 2025 to shareholders of record at the close of business on June 30, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Aankondiging • Jun 03
Extendicare Inc. (TSX:EXE) completed the acquisition of Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. Extendicare Inc. (TSX:EXE) has entered into an agreement to acquire Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. for CAD 60.3 million on November 28, 2024. As for the consideration, it was approximately $60.3 million, consisting of $40.2 million in cash and the assumption of $20.1 million in certain liabilities, including government funding reimbursement obligations and committed capital maintenance project obligations, excluding transaction costs. The purchase price was funded from cash on hand.The purchase price is expected to be funded from cash on hand and existing senior secured credit facilities. Closing of the Transaction is subject to customary closing conditions, including receipt of regulatory approvals from the Ontario Ministry of Long-Term Care, Ontario Retirement Home Regulatory Authority, and Manitoba Health and Winnipeg Regional Health Authority, and is not conditional on financing or due diligence. The Transaction is expected to close in the second quarter. Torys LLP is acting as legal advisor to Extendicare in connection with the Transaction. Stormont Partners is acting as financial advisor to Revera and Goodmans LLP is acting as legal advisor to Revera in connection with the Transaction.
Extendicare Inc. (TSX:EXE) completed the acquisition of Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. on June 1, 2025. Aankondiging • May 07
Extendicare Inc. Declares Cash Dividend for the Month of May 2025, Payable on June 16, 2025 The board of directors of Extendicare Inc. declared a cash dividend of CAD 0.042 per share for the month of May 2025, which is payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025. Aankondiging • Apr 16
Extendicare Inc Declares Cash Dividend for the Month of April 2025, Payable on May 15, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of April 2025, which is payable on May 15, 2025 to shareholders of record at the close of business on April 30, 2025. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). Aankondiging • Apr 03
Extendicare Inc. to Report Q1, 2025 Results on May 06, 2025 Extendicare Inc. announced that they will report Q1, 2025 results After-Market on May 06, 2025 Aankondiging • Mar 18
Extendicare Inc. Declares a Cash Dividend for the Month of March 2025, Payable on April 15, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company (the “Common Share”) for the month of March 2025, which is payable on April 15, 2025 to shareholders of record at the close of business on March 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Aankondiging • Mar 17
Extendicare Inc., Annual General Meeting, May 27, 2025 Extendicare Inc., Annual General Meeting, May 27, 2025. Location: ontario, toronto Canada Aankondiging • Feb 14
Extendicare Inc. Announces Cash Dividend for the Month of February 2025, Payable on March 17, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of February 2025, which is payable on March 17, 2025 to shareholders of record at the close of business on February 28, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Aankondiging • Jan 15
Extendicare Inc. Declares Cash Dividend for the Month of January 2025, Payable on February 14, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the company (the common share) for the month of January 2025, which is payable on February 14, 2025 to shareholders of record at the close of business on January 31, 2025. Aankondiging • Jan 13
Extendicare Inc. to Report Q4, 2024 Results on Feb 27, 2025 Extendicare Inc. announced that they will report Q4, 2024 results After-Market on Feb 27, 2025 Aankondiging • Dec 13
Extendicare Announces December 2024 Dividend, Payable on January 15, 2025 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of December 2024, which is payable on January 15, 2025 to shareholders of record at the close of business on December 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Reported Earnings • Nov 14
Third quarter 2024 earnings released: EPS: CA$0.20 (vs CA$0.14 in 3Q 2023) Third quarter 2024 results: EPS: CA$0.20 (up from CA$0.14 in 3Q 2023). Revenue: CA$359.1m (up 11% from 3Q 2023). Net income: CA$16.3m (up 38% from 3Q 2023). Profit margin: 4.5% (up from 3.7% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Aankondiging • Nov 13
Extendicare Inc. Declares Cash Dividend, Payable on December 16, 2024 The Board of Directors of Extendicare Inc. declared a cash dividend of $0.04 per share for the month of November 2024, which is payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024. Declared Dividend • Oct 18
Dividend of CA$0.04 announced Shareholders will receive a dividend of CA$0.04. Ex-date: 31st October 2024 Payment date: 15th November 2024 Dividend yield will be 5.5%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Aankondiging • Oct 15
Extendicare Inc. Declares Cash Dividend for the Month of October 2024, Payable on November 15, 2024 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of October 2024, which is payable on November 15, 2024 to shareholders of record at the close of business on October 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Aankondiging • Oct 04
Extendicare Inc. to Report Q3, 2024 Results on Nov 12, 2024 Extendicare Inc. announced that they will report Q3, 2024 results After-Market on Nov 12, 2024 Declared Dividend • Sep 19
Dividend of CA$0.04 announced Shareholders will receive a dividend of CA$0.04. Ex-date: 27th September 2024 Payment date: 15th October 2024 Dividend yield will be 5.7%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Aankondiging • Sep 16
Extendicare Inc. Announces Cash Dividend for the Month of September 2024, Payable on October 15, 2024 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of September 2024, which is payable on October 15, 2024 to shareholders of record at the close of business on September 30, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Declared Dividend • Aug 19
Dividend of CA$0.04 announced Shareholders will receive a dividend of CA$0.04. Ex-date: 30th August 2024 Payment date: 16th September 2024 Dividend yield will be 6.4%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Reported Earnings • Aug 13
Second quarter 2024 earnings released: EPS: CA$0.30 (vs CA$0.023 in 2Q 2023) Second quarter 2024 results: EPS: CA$0.30 (up from CA$0.023 in 2Q 2023). Revenue: CA$348.5m (up 13% from 2Q 2023). Net income: CA$25.9m (up CA$23.9m from 2Q 2023). Profit margin: 7.4% (up from 0.6% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Declared Dividend • Jul 22
Dividend of CA$0.04 announced Shareholders will receive a dividend of CA$0.04. Ex-date: 31st July 2024 Payment date: 15th August 2024 Dividend yield will be 6.9%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (114% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control, which is less than the 47% EPS growth achieved over the last 5 years. Aankondiging • Jul 15
Extendicare Inc. Announces July 2024 Cash Dividend, Payable on August 15, 2024 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of July 2024, which is payable on August 15, 2024 to shareholders of record at the close of business on July 31, 2024. Aankondiging • Jul 06
Extendicare Inc. to Report Q2, 2024 Results on Aug 12, 2024 Extendicare Inc. announced that they will report Q2, 2024 results After-Market on Aug 12, 2024 Recent Insider Transactions • Jul 05
Senior Vice President of ParaMed & CTO recently bought €67k worth of stock On the 28th of June, Steve Paraskevopoulos bought around 14k shares on-market at roughly €4.93 per share. This transaction amounted to 45% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €135k more in shares than they have sold in the last 12 months. Declared Dividend • Jun 24
Dividend of CA$0.04 announced Shareholders will receive a dividend of CA$0.04. Ex-date: 28th June 2024 Payment date: 15th July 2024 Dividend yield will be 7.0%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (114% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control, which is less than the 47% EPS growth achieved over the last 5 years. Aankondiging • Jun 18
Extendicare Inc. Declares Cash Dividend for the Month of June 2024, Payable on July 15, 2024 Extendicare Inc. announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of June 2024, which is payable on July 15, 2024 to shareholders of record at the close of business on June 28, 2024. Aankondiging • May 24
Extendicare Inc. Announces Alan Hibben Not Been Re-Elected as A Director Extendicare Inc. at the annual meeting of shareholders held on May 23, 2024 announced that Alan Hibben did not receive a majority of votes in favour at the Meeting and thus has not been re-elected as a director of Extendicare and resigned as such effective at the end of the Meeting. Declared Dividend • May 20
Dividend of CA$0.04 announced Shareholders will receive a dividend of CA$0.04. Ex-date: 31st May 2024 Payment date: 17th June 2024 Dividend yield will be 7.1%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (115% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control, which is less than the 47% EPS growth achieved over the last 5 years. Reported Earnings • May 17
First quarter 2024 earnings released: EPS: CA$0.16 (vs CA$0.14 in 1Q 2023) First quarter 2024 results: EPS: CA$0.16 (up from CA$0.14 in 1Q 2023). Revenue: CA$367.1m (up 13% from 1Q 2023). Net income: CA$13.1m (up 13% from 1Q 2023). Profit margin: 3.6% (in line with 1Q 2023). Revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Aankondiging • May 17
Extendicare Inc. Declares Cash Dividend for the Month of May 2024, Payable on June 17, 2024 The Board of Directors of Extendicare declared a cash dividend of $0.04 per share for the month of May 2024, which is payable on June 17, 2024, to shareholders of record at the close of business on May 31, 2024. Upcoming Dividend • Apr 25
Upcoming dividend of CA$0.04 per share Eligible shareholders must have bought the stock before 29 April 2024. Payment date: 15 May 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 6.6%. Within top quartile of German dividend payers (4.8%). Higher than average of industry peers (2.9%). Declared Dividend • Apr 23
Dividend of CA$0.04 announced Shareholders will receive a dividend of CA$0.04. Ex-date: 29th April 2024 Payment date: 15th May 2024 Dividend yield will be 7.1%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (120% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 33% to bring the payout ratio under control, which is less than the 35% EPS growth achieved over the last 5 years. Aankondiging • Apr 21
Extendicare Inc., Annual General Meeting, May 23, 2024 Extendicare Inc., Annual General Meeting, May 23, 2024, at 10:30 Eastern Daylight. Location: TMX Market Centre, 120 Adelaide Street West, Toronto Ontario Canada Agenda: To consider to receive the consolidated financial statements of the Company for the year ended December 31, 2023 and the report of the auditors thereon; to appoint the auditors of the Company and authorize the directors to fix the auditors remuneration; to elect the directors of the Company; to approve an advisory (non-binding) resolution to accept the approach of the Company to executive compensation disclosed in the Information Circular; and to discuss other matters. Aankondiging • Apr 15
Extendicare Inc. Declares Cash Dividend for the Month of April 2024, Payable on May 15, 2024 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of April 2024, which is payable on May 15, 2024 to shareholders of record at the close of business on April 30, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Aankondiging • Apr 05
Extendicare Inc. to Report Q1, 2024 Results on May 15, 2024 Extendicare Inc. announced that they will report Q1, 2024 results After-Market on May 15, 2024 Upcoming Dividend • Mar 20
Upcoming dividend of CA$0.04 per share Eligible shareholders must have bought the stock before 27 March 2024. Payment date: 15 April 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 6.2%. Within top quartile of German dividend payers (5.0%). Higher than average of industry peers (3.1%). Declared Dividend • Mar 18
Dividend of CA$0.04 announced Shareholders will receive a dividend of CA$0.04. Ex-date: 27th March 2024 Payment date: 15th April 2024 Dividend yield will be 7.0%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (120% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 33% to bring the payout ratio under control, which is less than the 35% EPS growth achieved over the last 5 years. Aankondiging • Mar 08
Extendicare Inc. Declares Cash Dividend for the Month of March 2024, Payable on April 15, 2024 The Board of Directors of Extendicare Inc. declared a cash dividend of CAD 0.04 per share for the month of March 2024, which is payable on April 15, 2024, to shareholders of record at the close of business on March 29, 2024. Reported Earnings • Mar 08
Full year 2023 earnings released: EPS: CA$0.40 (vs CA$0.051 loss in FY 2022) Full year 2023 results: EPS: CA$0.40 (up from CA$0.051 loss in FY 2022). Revenue: CA$1.30b (up 6.8% from FY 2022). Net income: CA$34.0m (up CA$38.5m from FY 2022). Profit margin: 2.6% (up from net loss in FY 2022). The move to profitability was driven by higher revenue. Revenue is forecast to grow 1.1% p.a. on average during the next 2 years, while revenues in the Healthcare industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Upcoming Dividend • Feb 21
Upcoming dividend of CA$0.04 per share Eligible shareholders must have bought the stock before 28 February 2024. Payment date: 15 March 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 7.1%. Within top quartile of German dividend payers (5.2%). Higher than average of industry peers (3.1%). Declared Dividend • Feb 19
Dividend of CA$0.04 announced Shareholders will receive a dividend of CA$0.04. Ex-date: 28th February 2024 Payment date: 15th March 2024 Dividend yield will be 7.2%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (233% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 158% to bring the payout ratio under control. However, EPS has declined by 7.3% over the last 5 years so the company would need to reverse this trend. Aankondiging • Feb 16
Extendicare Inc. Declares Cash Dividend for the Month of February 2024, Payable on March 15, 2024 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of February 2024, which is payable on March 15, 2024 to shareholders of record at the close of business on February 29, 2024. This dividend is designated as an eligible dividend within the meaning of the Income Tax Act (Canada). Upcoming Dividend • Jan 23
Upcoming dividend of CA$0.04 per share at 6.7% yield Eligible shareholders must have bought the stock before 30 January 2024. Payment date: 15 February 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 6.7%. Within top quartile of German dividend payers (5.0%). Higher than average of industry peers (3.3%). Aankondiging • Jan 20
Extendicare Inc. to Report Q4, 2023 Results on Mar 07, 2024 Extendicare Inc. announced that they will report Q4, 2023 results on Mar 07, 2024 Aankondiging • Dec 16
Extendicare Inc. Declares Cash Dividend for the Month of December 2023, Payable on January 15, 2024 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the Common Share) for the month of December 2023, which is payable on January 15, 2024 to shareholders of record at the close of business on December 29, 2023. Recent Insider Transactions • Dec 03
Independent Director recently bought €67k worth of stock On the 30th of November, Sandra Hanington bought around 14k shares on-market at roughly €4.70 per share. This transaction amounted to 56% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €579k more in shares than they have sold in the last 12 months. Upcoming Dividend • Nov 22
Upcoming dividend of CA$0.04 per share at 7.4% yield Eligible shareholders must have bought the stock before 29 November 2023. Payment date: 15 December 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 7.4%. Within top quartile of German dividend payers (5.0%). Higher than average of industry peers (3.2%). Reported Earnings • Nov 12
Third quarter 2023 earnings released: EPS: CA$0.14 (vs CA$0.049 loss in 3Q 2022) Third quarter 2023 results: EPS: CA$0.14 (up from CA$0.049 loss in 3Q 2022). Revenue: CA$322.5m (up 4.4% from 3Q 2022). Net income: CA$11.8m (up CA$16.2m from 3Q 2022). Profit margin: 3.7% (up from net loss in 3Q 2022). Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 1.0% decline forecast for the Healthcare industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance. Aankondiging • Nov 11
Extendicare Inc. Declares Cash Dividend for the Month of November 2023, Payable on December 15, 2023 The Board of Directors of Extendicare declared a cash dividend of $0.04 per share for the month of November 2023, which is payable on December 15, 2023, to shareholders of record at the close of business on November 30, 2023. Upcoming Dividend • Oct 23
Upcoming dividend of CA$0.04 per share at 7.9% yield Eligible shareholders must have bought the stock before 30 October 2023. Payment date: 15 November 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 7.9%. Within top quartile of German dividend payers (5.0%). Higher than average of industry peers (3.5%). Aankondiging • Oct 17
Extendicare Inc. Declares Cash Dividend for the Month of October 2023, Payable on November 15, 2023 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of October 2023, which is payable on November 15, 2023 to shareholders of record at the close of business on October 31, 2023. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Aankondiging • Oct 07
Extendicare Inc. to Report Q3, 2023 Results on Nov 09, 2023 Extendicare Inc. announced that they will report Q3, 2023 results at 4:00 PM, US Eastern Standard Time on Nov 09, 2023 Upcoming Dividend • Sep 21
Upcoming dividend of CA$0.04 per share at 7.8% yield Eligible shareholders must have bought the stock before 28 September 2023. Payment date: 16 October 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 7.8%. Within top quartile of German dividend payers (4.8%). Higher than average of industry peers (2.9%). Aankondiging • Sep 16
Extendicare Inc. Announces Cash Dividend for the September 2023, Payable on October 16, 2023 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of September 2023, which is payable on October 16, 2023 to shareholders of record at the close of business on September 29, 2023. Upcoming Dividend • Aug 23
Upcoming dividend of CA$0.04 per share at 7.4% yield Eligible shareholders must have bought the stock before 30 August 2023. Payment date: 15 September 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 7.4%. Within top quartile of German dividend payers (4.9%). Higher than average of industry peers (3.0%). New Risk • Aug 11
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 0.1% Last year net profit margin: 0.5% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (6.2% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Dividend per share is over 14x earnings per share. Paying a dividend despite having no free cash flows. Earnings have declined by 14% per year over the past 5 years. High level of non-cash earnings (32% accrual ratio). Minor Risk Profit margins are more than 30% lower than last year (0.1% net profit margin). Aankondiging • Aug 11
Extendicare Inc. Declares Cash Dividend for the Month of August 2023, Payable on September 15, 2023 The Board of Directors of Extendicare declared a cash dividend of $0.04 per share for the month of August 2023, which is payable on September 15, 2023, to shareholders of record at the close of business on August 31, 2023. This dividend is designated as an eligible dividend within the meaning of the Income Tax Act (Canada). Reported Earnings • Aug 11
Second quarter 2023 earnings released: EPS: CA$0.02 (vs CA$0.039 in 2Q 2022) Second quarter 2023 results: EPS: CA$0.02 (down from CA$0.039 in 2Q 2022). Revenue: CA$307.5m (up 3.7% from 2Q 2022). Net income: CA$1.95m (down 44% from 2Q 2022). Profit margin: 0.6% (down from 1.2% in 2Q 2022). Revenue is forecast to grow 5.1% p.a. on average during the next 2 years, compared to a 4.0% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance. Aankondiging • Aug 03
Extendicare Inc. (TSX:EXE) completed the acquisition of a 15 percent stake in a Portfolio of 24 Long Term Care Homes from Revera Inc. and Axium Infrastructure Inc. Extendicare Inc. (TSX:EXE) entered into an agreement to acquire a 15 percent stake in a Portfolio of 24 Long Term Care Homes from Revera Inc. on March 1, 2022. Extendicare will acquire a 15% managed interest in 18 “class A” long-term care homes located in Ontario and six homes in Manitoba. The remaining 85% interest will continue to be owned by an affiliate of Axium. Relatedly, on closing of the Acquisition, Extendicare will enter into management contracts with Revera to manage all of Revera’s other long-term care homes, which comprise 31 “class C” homes located in Ontario and one personal care home located in Manitoba. Extendicare will also enter into development arrangement agreements with Revera in respect of the potential redevelopment of those managed “class C” homes in Ontario into new homes. The aggregate cash consideration for the Transactions is approximately CAD 36.0 million plus the assumption of approximately CAD 34.0 million in debt, subject to customary adjustments. Certain of the associated debt will be refinanced or repaid on or before closing, resulting in changes in the allocation between cash consideration and debt assumption. The purchase price is expected to be funded from cash on hand. Closing of the Axium Transaction is subject to customary closing conditions, including receipt of regulatory approvals from the Ontario Ministry of Long-Term Care, and is not conditional on financing or due diligence. As of May 4, 2023, the transaction is expected to close by the end of Q3 2023. BMO Capital Markets is acting as financial advisor to Extendicare and Simon Knowling, Graham Rawlinson, Susan Nickerson, Craig Maurice and Nina Mansoori of Torys LLP is acting as legal advisor to Extendicare in connection with the Transactions. Stikeman Elliott LLP is acting as legal advisor to Axium in connection with the Transactions. Stormont Partners Advisory is acting as financial advisor to Revera and Goodmans LLP is acting as legal advisor to Revera in connection with the Revera Transactions.Extendicare Inc. (TSX:EXE) completed the acquisition of a 15 percent stake in a Portfolio of 24 Long Term Care Homes from Revera Inc. and Axium Infrastructure Inc. on August 1, 2022. Aankondiging • Jul 18
Extendicare Inc. Declares Cash Dividend for the Month of July 2023, Payable on August 15, 2023 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of July 2023, which is payable on August 15, 2023 to shareholders of record at the close of business on July 31, 2023. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). Aankondiging • Jul 07
Extendicare Inc. to Report Q2, 2023 Results on Aug 10, 2023 Extendicare Inc. announced that they will report Q2, 2023 results After-Market on Aug 10, 2023 Aankondiging • Jun 16
Extendicare Inc. Declares Cash Dividend for the Month of June 2023, Payable on July 17, 2023 Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the company (The Common Share) for the month of June 2023, which Is Payable on July 17, 2023 to shareholders of record At the close of business on June 30, 2023. Board Change • Jun 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. Independent Director Brent M. Houlden was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Recent Insider Transactions • May 31
Independent Director recently bought €74k worth of stock On the 26th of May, Brent M. Houlden bought around 15k shares on-market at roughly €4.92 per share. This trade did not impact their existing holding. In the last 3 months, there was an even bigger purchase from another insider worth €140k. Insiders have collectively bought €498k more in shares than they have sold in the last 12 months. Upcoming Dividend • May 23
Upcoming dividend of CA$0.04 per share at 6.6% yield Eligible shareholders must have bought the stock before 30 May 2023. Payment date: 15 June 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 6.6%. Within top quartile of German dividend payers (4.7%). Higher than average of industry peers (3.1%). Recent Insider Transactions • May 12
Senior Vice President of ParaMed & CTO recently bought €140k worth of stock On the 9th of May, Steve Paraskevopoulos bought around 30k shares on-market at roughly €4.66 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €424k more in shares than they have sold in the last 12 months. Reported Earnings • May 07
First quarter 2023 earnings released: EPS: CA$0.14 (vs CA$0.045 in 1Q 2022) First quarter 2023 results: EPS: CA$0.14 (up from CA$0.045 in 1Q 2022). Revenue: CA$324.7m (up 6.2% from 1Q 2022). Net income: CA$11.6m (up 186% from 1Q 2022). Profit margin: 3.6% (up from 1.3% in 1Q 2022). Revenue is forecast to grow 1.7% p.a. on average during the next 2 years, compared to a 3.9% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Recent Insider Transactions • Apr 03
CEO, President & Director recently bought €128k worth of stock On the 28th of March, Michael Guerriere bought around 30k shares on-market at roughly €4.26 per share. This transaction amounted to 18% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Michael's only on-market trade for the last 12 months. Upcoming Dividend • Mar 23
Upcoming dividend of CA$0.04 per share at 7.9% yield Eligible shareholders must have bought the stock before 30 March 2023. Payment date: 17 April 2023. The company is not currently making a profit and is not cash flow positive. Trailing yield: 7.9%. Within top quartile of German dividend payers (4.7%). Higher than average of industry peers (3.4%). Reported Earnings • Mar 03
Full year 2022 earnings released: CA$0.051 loss per share (vs CA$0.10 profit in FY 2021) Full year 2022 results: CA$0.051 loss per share (down from CA$0.10 profit in FY 2021). Revenue: CA$1.22b (flat on FY 2021). Net loss: CA$4.51m (down 150% from profit in FY 2021). Revenue is forecast to grow 1.9% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. 
